Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/05/2008EP1894563A1 Plaster containing fentanylum
03/05/2008EP1894562A1 Pharmaceutical compositions
03/05/2008EP1894561A1 Dipyridamole pharmaceutical compositions
03/05/2008EP1894560A1 Oral antimicrobial pharmaceutical compositions comprising metronidazole
03/05/2008EP1894559A1 Means to solubilise steroids for inhalation
03/05/2008EP1894557A1 Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore
03/05/2008EP1893649A2 Method for the potentiation of opioid analgesics effects on pain
03/05/2008EP1893630A1 Steroids having a mixed androgenic and progestagenic profile
03/05/2008EP1893629A1 Antiviral compounds
03/05/2008EP1893625A2 Methods for the preparation of 9-deazapurine derivatives
03/05/2008EP1893620A2 Substituted spiro compounds and their use for producing pain-relief drugs
03/05/2008EP1893619A1 New oxabispidine compounds for the treatment of cardiac arrhytmias
03/05/2008EP1893617A1 Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
03/05/2008EP1893615A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
03/05/2008EP1893614A1 Inhibitor compounds
03/05/2008EP1893613A1 Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders
03/05/2008EP1893612A1 Pyrrolo [2, 3-b]pyridine derivatives as protein kinase inhibitors
03/05/2008EP1893611A1 Ergoline derivatives and their use as chemokine receptor ligands
03/05/2008EP1893610A2 Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists
03/05/2008EP1893609A1 N-(pyridin-2-yl)-sulfonamide derivatives
03/05/2008EP1893608A2 Thiazolyl mglur5 antagonists and methods for their use
03/05/2008EP1893607A2 Inhibitors of checkpoint kinases
03/05/2008EP1893606A2 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
03/05/2008EP1893603A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
03/05/2008EP1893601A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
03/05/2008EP1893600A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
03/05/2008EP1893598A1 Alkylquinoline and alkylquinazoline kinase modulators
03/05/2008EP1893597A2 Ampa receptor potentiators
03/05/2008EP1893596A2 Benzoýb¨furane and benzoýb¨thiophene derivatives
03/05/2008EP1893593A1 3-phenylazetidine derivatives as dopamine agonists
03/05/2008EP1893592A1 Oxadiazole derivatives as dgat inhibitors
03/05/2008EP1893591A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
03/05/2008EP1893590A1 Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
03/05/2008EP1893589A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments
03/05/2008EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/05/2008EP1893584A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors
03/05/2008EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
03/05/2008EP1893582A2 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
03/05/2008EP1893580A1 NOVEL SALT FORM OF A ß2 -ADRENERGIC AGONIST QUINOLIN-2-ONE DERIVATIVE
03/05/2008EP1893579A1 1-hydroxycycloalkanecarboxamide derivatives as bradykinin antagonists
03/05/2008EP1893578A2 Novel piperidine carboxylic acid amide derivatives
03/05/2008EP1893577A1 Biphenyl compounds useful as muscarinic receptor antagonists
03/05/2008EP1893576A1 Treatment of protein folding disorders
03/05/2008EP1893575A2 2-(1h-indolylsulfanyl)-aryl amine derivatives
03/05/2008EP1893574A2 Peptide deformylase (pdf) inhibitors 4
03/05/2008EP1893573A1 Inhibitors of hcv replication
03/05/2008EP1893572A2 Factor xa inhibitors
03/05/2008EP1893569A1 Sulfonamide compounds and uses thereof
03/05/2008EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
03/05/2008EP1893562A1 Reversible inhibitors of monoamine oxidase a and b
03/05/2008EP1893561A1 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents
03/05/2008EP1893559A2 Process for preparation of sertraline hydrochloride form i
03/05/2008EP1893327A1 Installation for guiding a gas for devices used to treat granular products by drying, film-coating or coating, especially an incoming air unit, and device comprising one such installation
03/05/2008EP1893291A1 Treatment of sexual dysfunction
03/05/2008EP1893237A1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle
03/05/2008EP1893236A2 Direct compression formulation of dpp-iv inhibitors and glitazones, and process
03/05/2008EP1893222A2 Anti-hypercholesterolemic compounds
03/05/2008EP1893221A2 Synergistic prebiotic compositions
03/05/2008EP1893220A1 Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
03/05/2008EP1893219A2 Use of spirostenols to treat mitochondrial disorders
03/05/2008EP1893218A2 Unsolvated benzodiazepine compositions and methods
03/05/2008EP1893217A2 Tanaproget compositions containing ethinyl estradiol
03/05/2008EP1893216A1 Methods and compositions for the treatment of ocular disorders
03/05/2008EP1893215A1 Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
03/05/2008EP1893214A1 Synergistic modulation of flt3 kinase using alkylquinolines and alkylquinazolines
03/05/2008EP1893213A1 Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
03/05/2008EP1893212A2 Multicyclic compounds and methods of their use
03/05/2008EP1893211A1 Use of sanglifehrin in hcv
03/05/2008EP1893210A2 Selective apoptotic induction in cancer cells including activation of procaspase-3
03/05/2008EP1893209A2 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
03/05/2008EP1893208A1 Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder
03/05/2008EP1893207A1 Use of substituted piperazine derivatives and morpholine derivatives
03/05/2008EP1893206A2 Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
03/05/2008EP1893205A2 Dosage regimen for prasugrel
03/05/2008EP1893204A2 Formulations comprising fluphenazine or derivatives thereof
03/05/2008EP1893203A2 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
03/05/2008EP1893202A2 Multimediator dopamine transport inhibitors, and uses related thereto
03/05/2008EP1893201A1 Novel compounds of the family of iminosugars, uses thereof for treating lysosomal diseases, and method for preparing same
03/05/2008EP1893200A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
03/05/2008EP1893199A2 Pdz-domain modulators
03/05/2008EP1893198A2 Treatment of liver diseases in which iron plays a role in pathogenesis
03/05/2008EP1893197A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
03/05/2008EP1893196A1 Diarylhydantoin compounds
03/05/2008EP1893195A2 Polymorphic forms of tegaserod maleate
03/05/2008EP1893194A1 Enhanced indolinone based protein kinase inhibitors
03/05/2008EP1893193A2 Use of brivaracetam for the treatment of diseases characterized by progressive myoclonic epilepsy
03/05/2008EP1893191A1 Medicinal acidic cannabinoids
03/05/2008EP1893190A2 Methods and compositions for treating pain
03/05/2008EP1893189A2 Use of hydroxy tetrahydro-naphthalene derivatives for the treatment of respiratory diseases
03/05/2008EP1893188A1 Compounds useful for treating bipolar disorders
03/05/2008EP1893187A2 Improved antimicrobial peroxidase compositions
03/05/2008EP1893186A2 Improved treatment for anemia using a hif-alpha stabilising agent
03/05/2008EP1893185A2 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases
03/05/2008EP1893179A2 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
03/05/2008EP1893178A1 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS
03/05/2008EP1893176A1 Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying
03/05/2008EP1893175A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
03/05/2008EP1893173A1 Hair and/or scalp care compositions incorporating amino-oxo-indole-ylidene compounds
03/05/2008EP1893159A1 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
03/05/2008EP1893144A1 Medical devices and methods for producing the same
1 ... 3354 3355 3356 3357 3358 3359 3360 3361 3362 3363 3364 3365 3366 3367 3368 3369 3370 3371 3372 3373 3374 ... 7860